ProThera Biologics Named Entrepreneurial Track Winner in Year's RI Business Plan Competition
Published on May 6, 2010
Prothera Biologics, a spin-off of Brown University and two-time past and present RI Research Alliance Collaborative Grant Awardee, was named winner of the Entrepreneurial Track in the 2010 RI Business Plan Competition. The winning project, submitted by Richard Andrews of East Providence, proposes to develop inter-alpha inhibitor proteins to treat systemic inflammatory response syndrome and sepsis.
The company, established in 2001 by Yow-Pin Lim, MD/PhD, Assistant Professor of Medicine, Brown Medical School and Douglas C. Hixson, PhD, Professor of Medicine and Pathology/ Laboratory Medicine, Brown Medical School, focuses on unmet medical needs by developing integrated theranostic and therapeutic biomolecules for serious human diseases. ProThera was awarded a RI Research Alliance Collaborative Grant award in both 2008 and 2010 for their collaborative work developing therapies to increase success rates for complicated pregnancies and prevent prenatal brain damage.
This year's other winners include Speramus, an online fundraising platform that matches donors with individual support opportunities, and Newport Biodiesel, who is developing a sustainable method to manufacture biodiesel through local collection of waste vegetable oil.
Read about ProThera Biologics' collaborative work dealing with complicated pregnancies here.
Read about ProThera Biologics' collaborative work dealing with prenatal brain damage here.